Guidance | Page 3 of 4 | The British Society of Gastroenterology

Guidance

First published on 04 Apr 2017

BSG guidance on the use of intravenous hyoscine butylbromide (buscopan) during gastrointestinal endoscopy

The MHRA has recently circulated a Drug Safety Update regarding the risk of serious adverse events following the use of intravenous Hyoscine Butylbromide (Buscopan) in patients with underlying cardiac disease. Buscopan is commonly used during endoscopic procedures. It induces smooth […]

Guidance

First published on 01 Feb 2017

NICE guidance on molecular testing strategies for Lynch syndrome in people with colorectal cancer

An estimated 175,000 people have Lynch syndrome in the UK, however 95% of those do not know they have it. NICE recommends that microsatellite instability (MSI) testing or immunohistochemistry (IHC) should be used on all colorectal cancers, when first diagnosed, […]

Guidance

First published on 04 Oct 2016

Rapid Colorectal Diagnostic Pathway

Following extensive discussion and a multi-stakeholder workshop with NHS England in late 2016 a set of principles has been agreed for a Rapid Colorectal Diagnostic Pathway following the introduction of a non-mandated Best Practice Tariff in England. The BSG recommends […]

Guidance

First published on 01 Oct 2016

Test and treat for Helicobacter pylori (HP) in Dyspepsia

Helicobacter pylori in dyspepsia: test and treat – consultation and guidance documents from Public Health England. Guidance for primary care/ CCGs published October 2016. This guidance has been endorsed by members of the BSG Gastroduodenal Section. https://www.gov.uk/government/publications/helicobacter-pylori-diagnosis-and-treatment

Guidance

First published on 01 Feb 2016

Treatment Recommendations for the management of patients with chronic HCV Infection

These recommendations were developed at a consensus meeting of clinicians and interested parties on 5 January 2016. Therapies that are NICE approved are presented in bold and those that are NICE unapproved are italicised. The prices of the different regimens […]

Guidance

First published on 25 Nov 2015

NICE guidance on Daclatasvir for treating chronic hepatitis C

NICE technology appraisal guidance [TA364] Published date: November 2015

Guidance

First published on 25 Nov 2015

NICE guidance on Ledipasvir–Sofosbuvir for treating chronic hepatitis C

Guidance

First published on 27 Oct 2015

UK Key Performance Indicators and Quality Assurance Standards for Colonoscopy

Authors Rees CJ, Thomas-Gibson S, Rutter MD, Baragwanath P, Pullan R, Feeney M, Haslam N. Colonoscopy is the ‘gold standard’ investigation for assessment of the large bowel allowing diagnosis, biopsying, and therapy to be undertaken. Colonoscopy detects and prevents colorectal […]

Guidance

First published on 25 Oct 2015

NICE guidance on Ombitasvir–Paritaprevir–Ritonavir with or without Dasabuvir for treating chronic hepatitis C

NICE technology appraisal guidance [TA365] Published date: November 2015

Guidance

First published on 22 Oct 2015

NHS England service specification for Operational Delivery Networks for hepatitis C care in adults

22nd October 2015 NHS England has published the service specification for Operational Delivery Networks (ODNs) for hepatitis C care in adults. The full document is available below. Many BSG members will have been involved in the set up processes to date […]